Skip to main content
. 2015 Oct 14;6(34):36245–36259. doi: 10.18632/oncotarget.5768

Figure 1. Axitinib inhibits RCC cell viability in a dose and time-dependent manner.

Figure 1

A. A-498 and Caki-2 RCC cell lines were cultured up to 96 h with different doses of axitinib. Cell viability was determined by MTT assay. Data shown are expressed as mean ± SD of three separate experiments; *p < 0.01 vs vehicle-treated cells. B. RCC cell lines were cultured for 96 h with different doses of axitinib. Cell viability was determined by MTT assay. Data shown are expressed as mean ± SE of three separate experiments.